Fenbendazole and Ivermectin—two widely available drugs originally designed to treat parasites—are now at the center of a growing conversation about their potential role in cancer treatment. Patients and researchers alike are asking: Could these low-cost medications help slow tumor growth, enhance conventional treatments, and improve survival?

This book takes an in-depth look at the science, the stories, and the growing body of research behind fenbendazole and ivermectin, exploring why these drugs are gaining attention and how they may work against cancer.